A 'molecular' look at prostate cancer boosts treatment options
![](https://projects.research-and-innovation.ec.europa.eu/sites/default/files/styles/medium/public/successstory/31_03_20_small.jpg?itok=_DYQpPQU)
Treatment guidance for prostate cancer patients is not optimal because current clinical tests do not clearly differentiate between slow-growing and aggressive forms. An EU-funded project is addressing this by studying the underlying molecular mechanisms of the disease to enable personalised and effective treatment.